Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-24-249180
Filing Date
2024-11-01
Accepted
2024-11-01 07:06:06
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 d897170ds3.htm S-3 422557
2 EX-1.2 d897170dex12.htm EX-1.2 171037
3 EX-5.1 d897170dex51.htm EX-5.1 30038
4 EX-5.2 d897170dex52.htm EX-5.2 10234
5 EX-23.3 d897170dex233.htm EX-23.3 2808
6 EX-FILING FEES d897170dexfilingfees.htm EX-FILING FEES 64443
7 GRAPHIC g897170dsp64.jpg GRAPHIC 3734
8 GRAPHIC g897170g04m16.jpg GRAPHIC 37664
9 GRAPHIC g897170g1029074538245.jpg GRAPHIC 2246
  Complete submission text file 0001193125-24-249180.txt   762692
Mailing Address 919 WEST DILLON ROAD LOUISVILLE CO 80027
Business Address 919 WEST DILLON ROAD LOUISVILLE CO 80027 303-417-0500
BIODESIX INC (Filer) CIK: 0001439725 (see all company filings)

EIN.: 203986492 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-282938 | Film No.: 241417041
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)